The EU-PNAFLD (The European Paediatric NALFD Registry) will be a network composed of European centres involved in the care of children with NAFLD, and will include Hepatologists, Endocrinologists, and Scientists, supported by relevant international specialists. This collaboration will build on existing infrastructure (local databases and bio-repositories) and will align with the adult European NAFLD Registry ("EPoS", Elucidating Pathways of Steatohepatitis study) to allow long-term follow-up supported by translational studies. Through an international, well-characterised large-scale cohort, we hope to: facilitate multi-centre clinical trials; extend our understanding of the key disease mechanisms of NAFLD; and establish the natural history of paediatric NAFLD.
Study Type
OBSERVATIONAL
Enrollment
2,000
Maastricht UMC
Maastricht, Netherlands
ACTIVE_NOT_RECRUITINGAddenbrooke's Hospital
Cambridge, Cambridgeshire, United Kingdom
RECRUITINGBirmingham Children's Hospital
Birmingham, United Kingdom
RECRUITINGSurvival
All-cause survival
Time frame: 30-year follow-up
Cardiovascular morbidity
CAD, CVA, PAD
Time frame: 30-year follow-up
Liver morbidity
Decompensated liver disease, transplantation, HCC development
Time frame: 30-year follow-up
Asymptomatic progression of liver disease
Presence of advanced fibrosis (on biopsy or non-invasive imaging)
Time frame: 30-year follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.